Oxidative
stress plays a vital role in the development of cerebral
ischemic/reperfusion (I/R). Targeting oxidative stress is proposed
to be an effective strategy to treat cerebral I/R injury. Gentiana macrophylla Pall is reported to have a potential
protective effect against stroke. Swertiamarin (Swe), an active secoiridoid
glycoside compound isolated from Gentiana macrophylla Pall, has been reported to possess antioxidative potential. This
study is to explore whether Swe could prevent brain from I/R injury,
and the related mechanisms of oxidative stress are also elucidated
using mice middle cerebral artery occlusion (MCAO) model and primary
hippocampal neurons oxygen-glucose deprivation/reperfusion (OGD/R)
model. Swe (25, 100, or 400 mg/kg) was pretreated intraperitoneally
for 7 days until establishment of the MCAO model, while hippocampal
neurons were maintained in Swe (0.1, 1, or 10 μM) in the entire
process of reoxygenation. The results indicated that Swe pretreatment
markedly decreased infarct volume, apoptotic neurons, and oxidative
damage and promoted neurologic recovery in vivo. It also decreased
reactive oxygen species (ROS) and increased cell viability in vitro.
Western blot analyses and immunofluorescence staining demonstrated
that Swe pretreatment promoted Nrf2 nuclear translocation from Keap1-Nrf2
complex and enhanced the expressions of NAD(P)H: quinone oxidoreductase-1
(NQO1) and heme oxygenase-1 (HO-1) both in vivo and in vitro, while
the expressions could be reversed by a Nrf2 inhibitor. The binding
mode of Keap1 with Swe was also proposed by covalent molecular docking.
Collectively, Swe could be considered as a promising protective agent
against cerebral I/R injury through suppressing oxidative stress by
activation of the Nrf2 protective pathway.